Neuravi, Ltd. FDA Approvals

0 new drug approvals and 2 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
EmboTrap II Revascularization Device, EMBOTRAP III Revascularization Device510(k)Oct 13, 2021Cardiovascular	Cardiovascular	510(k)Substantially Equivalent (Special)	Oct 13, 2021
EMBOTRAP III Revascularization Device510(k)Jul 30, 2021Cardiovascular	Cardiovascular	510(k)Substantially Equivalent (Traditional)	Jul 30, 2021